KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Current Taxes (2016 - 2025)

Biogen (BIIB) has 17 years of Current Taxes data on record, last reported at $114.8 million in Q4 2025.

  • For Q4 2025, Current Taxes fell 79.06% year-over-year to $114.8 million; the TTM value through Dec 2025 reached $114.8 million, down 79.06%, while the annual FY2025 figure was $114.8 million, 79.06% down from the prior year.
  • Current Taxes reached $114.8 million in Q4 2025 per BIIB's latest filing, up from $103.3 million in the prior quarter.
  • Across five years, Current Taxes topped out at $626.1 million in Q1 2025 and bottomed at $103.3 million in Q3 2025.
  • Average Current Taxes over 5 years is $269.9 million, with a median of $240.6 million recorded in 2022.
  • The widest YoY moves for Current Taxes: up 170.8% in 2025, down 79.3% in 2025.
  • A 5-year view of Current Taxes shows it stood at $174.7 million in 2021, then soared by 48.77% to $259.9 million in 2022, then decreased by 0.96% to $257.4 million in 2023, then skyrocketed by 113.01% to $548.3 million in 2024, then crashed by 79.06% to $114.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $114.8 million in Q4 2025, $103.3 million in Q3 2025, and $114.8 million in Q2 2025.